TherapeuticsMD Inc. buy stratec
Start price
26.10.18
/
50%
€242.64
Target price
04.11.21
€200.00
Performance (%)
-86.61%
End price
05.11.21
€32.50
Summary
This prediction ended on 05.11.21 with a price of €32.50. Massive losses of -86.61% were the result for the BUY prediction by stratec. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| TherapeuticsMD Inc. | 5.389% | 5.389% | 83.333% | -50.838% |
| iShares Core DAX® | -1,02 % | -1,14 % | 1,59 % | 50,96 % |
| iShares Nasdaq 100 | -2,52 % | -5,25 % | 26,60 % | 82,15 % |
| iShares Nikkei 225® | -4,44 % | -10,16 % | 53,01 % | 68,74 % |
| iShares S&P 500 | -1,23 % | -0,04 % | 21,56 % | 65,37 % |
Comments by stratec for this prediction
In the thread Therapeuticsmd Inc. diskutieren
stratec stimmt der Buy-Einschätzung der institutionellen Analysten zu
TherapeuticsMD announces that it is discussing labeling with the FDA related to hormone therapy candidate TX-001HR.
The agency's action date for its proposed use for treating moderate-to-severe vasomotor symptoms due to menopause is October 28, but a decision may be announced today.
Kursziel geändert auf 4,0
In the thread Trading Therapeuticsmd Inc.
Die von stratec gewählte maximale Laufzeit wurde überschritten